Abstract
Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Current Pharmaceutical Biotechnology
Title: Microbubble: A Potential Ultrasound Tool in Molecular Imaging
Volume: 9 Issue: 5
Author(s): Rajesh M. Patel
Affiliation:
Keywords: Microbubble, ultrasound contrast agent, molecular imaging
Abstract: Advances in molecular biology and biochemistry have dramatically increased our understanding of disease. The molecular mechanisms are the pathogenic basis of disease is changing modern medicine. New drugs often inhibit specific key pathways. In nuclear medicine, molecular imaging agents have been used for years, but most contrast agents for MRI or CT today are unspecific. The diagnosis is based on alterations in morphology and basic physiology, all of which are late manifestations of the original molecular changes. There are only few more specific contrast agents available. Microbubbles are the one, of size of blood cells are used as contrast agents for ultrasound imaging and are particularly valuable for targeting selected tissues and for providing useful information about the efficacy of chemotherapy. The exploitation of microbubble agents can be achieved when there is a full understanding of the bubble/ultrasound interaction for microbubbles freely suspended in blood or attached to blood vessel walls. Microbubbles are promising tool for targeting chemotherapeutics, polypeptides and genetic material to its target in body.
Export Options
About this article
Cite this article as:
Patel M. Rajesh, Microbubble: A Potential Ultrasound Tool in Molecular Imaging, Current Pharmaceutical Biotechnology 2008; 9(5) . https://dx.doi.org/10.2174/138920108785915175
DOI https://dx.doi.org/10.2174/138920108785915175 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Vascular and Cardiac Oxidative Stress and Inflammation as Targets for Cardioprotection
Current Pharmaceutical Design Absorption, Disposition and Pharmacokinetics of Nanoemulsions
Current Drug Metabolism Caspases as Drug Targets in Ischemic Organ Injury
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Clinical Pharmacology of Ibuprofen and Indomethacin in Preterm Infants with Patent Ductus Arteriosus
Current Pediatric Reviews Key Role of Mitochondria in Alzheimer’s Disease Synaptic Dysfunction
Current Pharmaceutical Design Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Drug Eluting Stents for Vulnerable Plague
Current Pharmaceutical Design Pharmacological Intervention in Type 2 Diabetes Mellitus – A Pathophysiologically Reasoned Approach?
Current Diabetes Reviews Novel Drug Targets for the Treatment of Cardiac Diseases
Current Pharmacogenomics and Personalized Medicine Antioxidants in the Practice of Medicine; What Should the Clinician Know?
Cardiovascular & Hematological Disorders-Drug Targets Effects of Endothelins on Cardiac and Vascular Cells: New Therapeutic Target for the Future?
Current Vascular Pharmacology Recent Advances in Transcranial Focused Ultrasound (FUS) Triggered Brain Delivery
Current Drug Targets Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Cell-penetrating Peptides as Nucleic Acid Delivery Systems: From Biophysics to Biological Applications
Current Pharmaceutical Design Genome Wide Analysis of Chlamydia pneumoniae for Candidate Vaccine Development
Current Computer-Aided Drug Design siRNA Delivery Using Nanocarriers – An Efficient Tool for Gene Silencing
Current Gene Therapy Gadolinium Oxide Nanoparticles as Potential Multimodal Imaging and Therapeutic Agents
Current Topics in Medicinal Chemistry The potential for circulating microRNAs in the diagnosis of myocardial infarction: a novel approach to disease diagnosis and treatment
Current Pharmaceutical Design Inflammatory Pathways in Knee Osteoarthritis: Potential Targets for Treatment
Current Rheumatology Reviews A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine
Current Pharmaceutical Design